PL
Planet Labs PBC
$31.64
▲ 0.8%Updated Today 12:11 PM ET
PL at a glance — five pillars scored 0–100 from real filed financials.
Overall: Weak · 26/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.
▲ Up 360.3% over the last 12 months
Market Cap
$11.18B
P/E
—
Forward P/E (est.)
—
ROE
-105.3%
Revenue Growth
34.1%
EPS Growth
—
Profit Margin
-111.2%
FCF Yield
-1.3%
Debt / Equity
2.37x
ROIC
-17.0%
Interest Coverage
—
Current Ratio
2.81x
Dividend Yield
—
Implied Growth (rev. DCF)
8.4%
Rating Score
26/100
Planet Labs PBC (PL) is a large-cap company in the Professional Services industry, part of the Industrials sector of the S&P 500, with a market value around $11.18B.
In its latest reported year it generated about $307.73M in revenue and posted a net loss of $246.86M.
Our model rates PL Weak (26/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what PL's chart says today, with each tool explained.
Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. PL trades near $31.64, around its 50-day average ($36.97) and 200-day average ($24.90). Price tangled in its moving averages means there is no clear trend — the stock is ranging.
Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 51 it is in neutral territory — neither stretched nor washed out.
MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently positive — short-term momentum is improving.
Volatility — ATR. Average True Range is the typical daily move. PL's is $2.65 (~8.4% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.
Support & resistance. Over the last month PL found buyers near $25.30 (support) and sellers near $39.18 (resistance); its 52-week range is $5.87–$51.76. A decisive break beyond either edge often marks the next move.
Volume. The latest session traded 0.2× the 20-day average — lighter than usual, so the move carries less conviction. Rising volume on up-days suggests real buying; on down-days, real selling.
Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.
4Y CAGR
23.8%
Revenue moved from $95.74M in 2020 to $307.73M in 2026, a 21.5% compound annual growth rate. The most recent year grew a strong 34.1% year over year. Consistent top-line growth is one sign of healthy demand.
Gross Margin
56.1%
Operating Margin
-30.9%
Net Margin
-80.2%
ROE
-105.3%
Planet Labs PBC keeps about -111.2% of each sales dollar as net profit, with a 56.1% gross margin and -30.9% operating margin. Return on equity is -105.3% and return on invested capital about -17.0%. The company is currently unprofitable on a net basis.
Total Debt
—
Net Debt
—
Net Debt / EBITDA
—
Debt / Equity
2.37x
Leverage: debt-to-equity is 2.4x, with a current ratio of 2.8x. That is elevated leverage, which raises risk if earnings or rates move against it.
Operating CF
$134.36M
Free Cash Flow
$57.65M
FCF Margin
18.7%
In the latest year Planet Labs PBC produced about $134.36M of operating cash flow and $57.65M of free cash flow after capital spending. That is a free-cash-flow yield of about -1.3% on today's price. Cash flow is what ultimately pays shareholders, so it is worth tracking over time.
P/E
—
P/S
36.34x
P/B
40.64x
EV / EBITDA
—
PL trades at n/a trailing earnings, 36.3x sales, and 40.6x book value. Reverse-engineering today's price implies the market expects roughly 8.4% long-term free-cash-flow growth. With no positive trailing earnings, value it on sales, cash flow, or growth rather than P/E.
A two-stage discounted cash flow on real SEC-filed free cash flow — the intrinsic-value anchor professional analysts triangulate from.
DCF fair value / share
$9.18
Current price
$31.64
Starting FCF (latest 10-K)
$57.65M
Growth, years 1–5
20.0%
Fade to terminal, years 6–10
2.5%
Discount rate
9.0%
Cash flows grow at the stage-1 rate (trailing revenue growth, capped at 20%) for five years, fade to 2.5% by year 10, and continue at that rate forever (Gordon terminal value), all discounted at 9.0%. Small changes in assumptions move the result a lot — treat this as one reference point, not a target price. Educational only, not investment advice.
Where this stock sits versus what most companies trade at.
Typical ranges are general references (e.g., many stocks trade at ~18–26x earnings), not hard rules. Context only — not investment advice.
Project revenue → earnings → price. Edit the assumptions to build your own case.
2030 price target (Base Case)
$0.00 – $0.00
vs. $31.64 today · expected CAGR -43% – -37%
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | $412.35M | $552.55M | $740.42M | $992.17M | $1.33B |
| Net income | $12.37M | $16.58M | $22.21M | $29.77M | $39.89M |
| EPS | $0.05 | $0.06 | $0.09 | $0.11 | $0.15 |
| Share price (low) | $0.57 | $0.76 | $1.02 | $1.37 | $1.84 |
| Share price (high) | $0.95 | $1.27 | $1.71 | $2.29 | $3.07 |
| CAGR (low–high) | -98% / -97% | -84% / -80% | -68% / -62% | -54% / -48% | -43% / -37% |
Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.
The case for PL:
- Revenue is growing 34.1% a year, a sign of real demand.
- As an established S&P 500 member in Industrials, it brings scale and a long operating history.
The case against PL:
- Thin net margins (-111.2%) leave little room for error.
- Elevated leverage (debt/equity 2.4x) adds financial risk.
- Limited free cash flow at today's price.
- Our model's overall read is Weak (26/100).
Balance-sheet risk — debt/equity of 2.4x magnifies the impact of higher rates or weaker earnings.
Margin risk — thin profitability (-111.2%) is vulnerable to cost or pricing pressure.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
On balance, the fundamentals screen weakly: Planet Labs PBC is a large-cap industrials business still growing nicely, with modest profitability, and a heavier debt load to watch. It trades at n/a earnings, which our model scores Weak (26/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
PL — frequently asked questions
Is PL a good stock to buy?
We don't give buy or sell advice. Our model rates Planet Labs PBC Weak (26/100) based on its growth, profitability, financial health, and valuation — use that as a research starting point and make your own decision.
What is PL's rating on The Stocks School?
Planet Labs PBC currently scores 26/100 (Weak) on our transparent model, which weighs real fundamentals: growth, margins, returns on capital, balance-sheet strength, and valuation.
How our ratings work →Where does PL's data come from?
Live price data plus real fundamentals and 5-year financials pulled directly from Planet Labs PBC's SEC filings — refreshed automatically, not hand-entered.
How is the 5-year projection for PL calculated?
It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.
Is this PL analysis financial advice?
No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell PL. Always do your own research and consider a licensed professional.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.